Nexomics Biosciences Email Formats

About Nexomics Biosciences

Nexomics Biosciences focuses on the discovery, development and commercialization of novel drugs focusing on cancer, antiviral and antibiotic treatments. Nexomics Biosciences also functions as a contract research organization (CRO), offering a broad array of gene-to-structure services to the biopharmaceutical community. We offer a variety of services from bioinformatics target profiling, gene cloning, recombinant protein expression, laboratory-scale fermentation, crystallization, NMR structural studies, X-ray crystallography structural studies, assay development, and functional annotation. Nexomics Biosciences aims to build a portfolio of intellectual property associated with structure-based assay development, protein production, and drug discovery. Our long term goal is development of a proprietary pharmaceutical discovery program based on characterizing disease related proteins and their molecular functions, and by identifying potential drug target binding compounds.

View contact profiles from Nexomics Biosciences